Journal
WORLD JOURNAL OF PEDIATRICS
Volume 18, Issue 5, Pages 320-332Publisher
ZHEJIANG UNIV PRESS
DOI: 10.1007/s12519-022-00516-6
Keywords
Abdominal pain; Adolescents; Irritable bowel syndrome; Meta-analysis; Probiotic
Categories
Ask authors/readers for more resources
Probiotic supplementation can reduce abdominal pain in pediatric patients with IBS, with stronger effects seen in patients under 10 years old and longer supplementation periods exceeding four weeks.
Background Probiotic supplementation has been used to alleviate abdominal pain in children and adolescents with irritable bowel syndrome (IBS), but the evidence is not compelling. Thus, a systematic review and meta-analysis of randomized clinical trials (RCTs) were performed to investigate the effects of probiotic supplementation on abdominal pain in pediatric patients with IBS. Methods PubMed/MEDLINE, Web of Science, Scopus, Cochrane Library, and Embase were the available databases searched to find relevant randomized clinical trials up to April 2021. The effect size was expressed as weighted mean difference (WMD) and 95% confidence interval (CI). Results Seven RCTs with 441 participants were included, from which the meta-analysis demonstrated that probiotic supplementation has a significant effect on reducing abdominal pain in pediatric patients with IBS (WMD = - 2.36; 95% CI - 4.12 to - 0.60; P = 0.009). Although our study involved children and adolescents (<= 18 years), the effects of probiotic supplementation seem to be more potent in patients under 10 years old (WMD = - 2.55; 95% CI - 2.84 to - 2.27) compared to patients aged 10-18 years (WMD = - 1.70; 95% CI - 2.18 to - 1.22). The length of supplementation longer than four weeks was more effective (WMD = - 2.43; 95% CI - 2.76 to - 2.09). Conclusion Probiotic supplementation can reduce abdominal pain in pediatric patients with IBS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available